microRNA 21-mediated suppression of sprouty1 by Pokemon affects liver cancer cell growth and proliferation
Transcriptional repressor Pokemon is a critical factor in embryogenesis, development, cell proliferation, differentiation, and oncogenesis, thus behaving as an oncogene. Oncomine database suggests a potential correlation between the expressions of Pokemon and Sprouty1. This study investigated the re...
Saved in:
Published in | Journal of cellular biochemistry Vol. 114; no. 7; pp. 1625 - 1633 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01.07.2013
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Transcriptional repressor Pokemon is a critical factor in embryogenesis, development, cell proliferation, differentiation, and oncogenesis, thus behaving as an oncogene. Oncomine database suggests a potential correlation between the expressions of Pokemon and Sprouty1. This study investigated the regulatory role of Pokemon in Sprouty1 expression and the effect on liver cancer cell growth and proliferation, revealing a novel miR‐21‐mediated regulatory circuit. In normal (HL‐7702) and cancer (QGY‐7703) liver cell lines, Sprouty1 expression is inversely correlated with Pokemon levels. Targeted expression or siRNA‐mediated silencing showed that Pokemon is a repressor of Sprouty1 expression at both mRNA and protein levels, but Pokemon cannot affect the promoter activity of Sprouty1. Sprouty1 is a target of miR‐21 and interestingly, we found that miR‐21 is up‐regulated by Pokemon in liver cancer cells. Luciferase reporter assays showed that Pokemon up‐regulated miR‐21 transcription in a dose‐dependent manner, and ChIP assay exhibited a direct binding of Pokemon to the miR‐21 promoter at −747 to −399 bp. Site‐directed mutagenesis of the GC boxes at −684 to −679 bp and −652 to −647 bp of miR‐21 promoter abolished the regulatory activity by Pokemon. Furthermore, we found that the modulation of Pokemon and miR‐21 expression affected the growth and proliferation of liver cancer cells QGY‐7703. In summary, our findings demonstrate that Pokemon suppresses Sprouty1 expression through a miR‐21‐mediated mechanism, affecting the growth and proliferation of liver cancer cells. This study recognized miR‐21 and Sprouty1 as novel targets of the Pokemon regulatory network. J. Cell. Biochem. 114: 1625–1633, 2013. © 2013 Wiley Periodicals, Inc. |
---|---|
AbstractList | Transcriptional repressor Pokemon is a critical factor in embryogenesis, development, cell proliferation, differentiation, and oncogenesis, thus behaving as an oncogene. Oncomine database suggests a potential correlation between the expressions of Pokemon and Sprouty1. This study investigated the regulatory role of Pokemon in Sprouty1 expression and the effect on liver cancer cell growth and proliferation, revealing a novel miR-21-mediated regulatory circuit. In normal (HL-7702) and cancer (QGY-7703) liver cell lines, Sprouty1 expression is inversely correlated with Pokemon levels. Targeted expression or siRNA-mediated silencing showed that Pokemon is a repressor of Sprouty1 expression at both mRNA and protein levels, but Pokemon cannot affect the promoter activity of Sprouty1. Sprouty1 is a target of miR-21 and interestingly, we found that miR-21 is up-regulated by Pokemon in liver cancer cells. Luciferase reporter assays showed that Pokemon up-regulated miR-21 transcription in a dose-dependent manner, and ChIP assay exhibited a direct binding of Pokemon to the miR-21 promoter at -747 to -399bp. Site-directed mutagenesis of the GC boxes at -684 to -679bp and -652 to -647bp of miR-21 promoter abolished the regulatory activity by Pokemon. Furthermore, we found that the modulation of Pokemon and miR-21 expression affected the growth and proliferation of liver cancer cells QGY-7703. In summary, our findings demonstrate that Pokemon suppresses Sprouty1 expression through a miR-21-mediated mechanism, affecting the growth and proliferation of liver cancer cells. This study recognized miR-21 and Sprouty1 as novel targets of the Pokemon regulatory network. J. Cell. Biochem. 114: 1625-1633, 2013. © 2013 Wiley Periodicals, Inc. [PUBLICATION ABSTRACT] Transcriptional repressor Pokemon is a critical factor in embryogenesis, development, cell proliferation, differentiation, and oncogenesis, thus behaving as an oncogene. Oncomine database suggests a potential correlation between the expressions of Pokemon and Sprouty1. This study investigated the regulatory role of Pokemon in Sprouty1 expression and the effect on liver cancer cell growth and proliferation, revealing a novel miR‐21‐mediated regulatory circuit. In normal (HL‐7702) and cancer (QGY‐7703) liver cell lines, Sprouty1 expression is inversely correlated with Pokemon levels. Targeted expression or siRNA‐mediated silencing showed that Pokemon is a repressor of Sprouty1 expression at both mRNA and protein levels, but Pokemon cannot affect the promoter activity of Sprouty1. Sprouty1 is a target of miR‐21 and interestingly, we found that miR‐21 is up‐regulated by Pokemon in liver cancer cells. Luciferase reporter assays showed that Pokemon up‐regulated miR‐21 transcription in a dose‐dependent manner, and ChIP assay exhibited a direct binding of Pokemon to the miR‐21 promoter at −747 to −399 bp. Site‐directed mutagenesis of the GC boxes at −684 to −679 bp and −652 to −647 bp of miR‐21 promoter abolished the regulatory activity by Pokemon. Furthermore, we found that the modulation of Pokemon and miR‐21 expression affected the growth and proliferation of liver cancer cells QGY‐7703. In summary, our findings demonstrate that Pokemon suppresses Sprouty1 expression through a miR‐21‐mediated mechanism, affecting the growth and proliferation of liver cancer cells. This study recognized miR‐21 and Sprouty1 as novel targets of the Pokemon regulatory network. J. Cell. Biochem. 114: 1625–1633, 2013. © 2013 Wiley Periodicals, Inc. Transcriptional repressor Pokemon is a critical factor in embryogenesis, development, cell proliferation, differentiation, and oncogenesis, thus behaving as an oncogene. Oncomine database suggests a potential correlation between the expressions of Pokemon and Sprouty1. This study investigated the regulatory role of Pokemon in Sprouty1 expression and the effect on liver cancer cell growth and proliferation, revealing a novel miR-21-mediated regulatory circuit. In normal (HL-7702) and cancer (QGY-7703) liver cell lines, Sprouty1 expression is inversely correlated with Pokemon levels. Targeted expression or siRNA-mediated silencing showed that Pokemon is a repressor of Sprouty1 expression at both mRNA and protein levels, but Pokemon cannot affect the promoter activity of Sprouty1. Sprouty1 is a target of miR-21 and interestingly, we found that miR-21 is up-regulated by Pokemon in liver cancer cells. Luciferase reporter assays showed that Pokemon up-regulated miR-21 transcription in a dose-dependent manner, and ChIP assay exhibited a direct binding of Pokemon to the miR-21 promoter at -747 to -399 bp. Site-directed mutagenesis of the GC boxes at -684 to -679 bp and -652 to -647 bp of miR-21 promoter abolished the regulatory activity by Pokemon. Furthermore, we found that the modulation of Pokemon and miR-21 expression affected the growth and proliferation of liver cancer cells QGY-7703. In summary, our findings demonstrate that Pokemon suppresses Sprouty1 expression through a miR-21-mediated mechanism, affecting the growth and proliferation of liver cancer cells. This study recognized miR-21 and Sprouty1 as novel targets of the Pokemon regulatory network.Transcriptional repressor Pokemon is a critical factor in embryogenesis, development, cell proliferation, differentiation, and oncogenesis, thus behaving as an oncogene. Oncomine database suggests a potential correlation between the expressions of Pokemon and Sprouty1. This study investigated the regulatory role of Pokemon in Sprouty1 expression and the effect on liver cancer cell growth and proliferation, revealing a novel miR-21-mediated regulatory circuit. In normal (HL-7702) and cancer (QGY-7703) liver cell lines, Sprouty1 expression is inversely correlated with Pokemon levels. Targeted expression or siRNA-mediated silencing showed that Pokemon is a repressor of Sprouty1 expression at both mRNA and protein levels, but Pokemon cannot affect the promoter activity of Sprouty1. Sprouty1 is a target of miR-21 and interestingly, we found that miR-21 is up-regulated by Pokemon in liver cancer cells. Luciferase reporter assays showed that Pokemon up-regulated miR-21 transcription in a dose-dependent manner, and ChIP assay exhibited a direct binding of Pokemon to the miR-21 promoter at -747 to -399 bp. Site-directed mutagenesis of the GC boxes at -684 to -679 bp and -652 to -647 bp of miR-21 promoter abolished the regulatory activity by Pokemon. Furthermore, we found that the modulation of Pokemon and miR-21 expression affected the growth and proliferation of liver cancer cells QGY-7703. In summary, our findings demonstrate that Pokemon suppresses Sprouty1 expression through a miR-21-mediated mechanism, affecting the growth and proliferation of liver cancer cells. This study recognized miR-21 and Sprouty1 as novel targets of the Pokemon regulatory network. Transcriptional repressor Pokemon is a critical factor in embryogenesis, development, cell proliferation, differentiation, and oncogenesis, thus behaving as an oncogene. Oncomine database suggests a potential correlation between the expressions of Pokemon and Sprouty1. This study investigated the regulatory role of Pokemon in Sprouty1 expression and the effect on liver cancer cell growth and proliferation, revealing a novel miR-21-mediated regulatory circuit. In normal (HL-7702) and cancer (QGY-7703) liver cell lines, Sprouty1 expression is inversely correlated with Pokemon levels. Targeted expression or siRNA-mediated silencing showed that Pokemon is a repressor of Sprouty1 expression at both mRNA and protein levels, but Pokemon cannot affect the promoter activity of Sprouty1. Sprouty1 is a target of miR-21 and interestingly, we found that miR-21 is up-regulated by Pokemon in liver cancer cells. Luciferase reporter assays showed that Pokemon up-regulated miR-21 transcription in a dose-dependent manner, and ChIP assay exhibited a direct binding of Pokemon to the miR-21 promoter at -747 to -399 bp. Site-directed mutagenesis of the GC boxes at -684 to -679 bp and -652 to -647 bp of miR-21 promoter abolished the regulatory activity by Pokemon. Furthermore, we found that the modulation of Pokemon and miR-21 expression affected the growth and proliferation of liver cancer cells QGY-7703. In summary, our findings demonstrate that Pokemon suppresses Sprouty1 expression through a miR-21-mediated mechanism, affecting the growth and proliferation of liver cancer cells. This study recognized miR-21 and Sprouty1 as novel targets of the Pokemon regulatory network. |
Author | Yang, Hong-Wei Sun, Qin-Sheng Liu, Feng Jiang, Yu-Yang Liu, Hong-Xia Jin, Xiu-Li Liu, Min Xu, Wei |
Author_xml | – sequence: 1 givenname: Xiu-Li surname: Jin fullname: Jin, Xiu-Li organization: The State Key Laboratory Breeding Base-Shenzhen Key Laboratory of Chemical Biology, The Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, P. R. China – sequence: 2 givenname: Qin-Sheng surname: Sun fullname: Sun, Qin-Sheng organization: The State Key Laboratory Breeding Base-Shenzhen Key Laboratory of Chemical Biology, The Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, P. R. China – sequence: 3 givenname: Feng surname: Liu fullname: Liu, Feng organization: The State Key Laboratory Breeding Base-Shenzhen Key Laboratory of Chemical Biology, The Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, P. R. China – sequence: 4 givenname: Hong-Wei surname: Yang fullname: Yang, Hong-Wei organization: The State Key Laboratory Breeding Base-Shenzhen Key Laboratory of Chemical Biology, The Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, P. R. China – sequence: 5 givenname: Min surname: Liu fullname: Liu, Min organization: The State Key Laboratory Breeding Base-Shenzhen Key Laboratory of Chemical Biology, The Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, P. R. China – sequence: 6 givenname: Hong-Xia surname: Liu fullname: Liu, Hong-Xia organization: The State Key Laboratory Breeding Base-Shenzhen Key Laboratory of Chemical Biology, The Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, P. R. China – sequence: 7 givenname: Wei surname: Xu fullname: Xu, Wei email: shxuwei8720@163.com organization: School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China – sequence: 8 givenname: Yu-Yang surname: Jiang fullname: Jiang, Yu-Yang email: jiangyy@sz.tsinghua.edu.cn organization: The State Key Laboratory Breeding Base-Shenzhen Key Laboratory of Chemical Biology, The Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, P. R. China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23355454$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kUtvEzEUhS1URNPCgj-ALLGhi2n9drwsKTSgUCoe6tLyONfgdDIT7JmW_HucJmFRwepK1neO7z3nCB20XQsIvaTklBLCzha-PmVCEvEEjSgxuhJKiAM0IpqTinHKDtFRzgtCiDGcPUOHjHMphRQjtFhGn7ovV-eY0WoJ8-h6mOM8rFYJco5di7uA8yp1Q7-muF7j6-4WluXZhQC-z7iJd5Cwd63fDGga_CN19_1P7No5LromBkiuL07P0dPgmgwvdvMYfX__7ttkWs0-X36YnM8qzw0VlXLGkHHN5pRz5nmQpq61ckpwo3jQLgimvR-DVAASAtXaK10HXkvKRS0dP0Zvtr7l918D5N4uY95s5lrohmwpl2RshKLjgr5-hC66IbVlu0IJo3XJSBXq1Y4a6hKRXaW4dGlt9ykW4GwLlChzThCsj_3DzX1ysbGU2E1PtvRkH3oqipNHir3pv9id-31sYP1_0H6cvN0rqq0i5h5-_1W4dGuV5lram6tLez39Orv4dDG1N_wPtKuv8g |
CitedBy_id | crossref_primary_10_1016_j_jconrel_2015_08_009 crossref_primary_10_1155_2013_804128 crossref_primary_10_1016_j_nano_2019_102063 crossref_primary_10_1089_rej_2016_1829 crossref_primary_10_1016_j_bbrep_2021_101026 crossref_primary_10_1002_ddr_21270 crossref_primary_10_7314_APJCP_2013_14_11_6315 crossref_primary_10_1007_s12072_015_9697_y crossref_primary_10_2217_pgs_13_143 crossref_primary_10_1016_S1665_2681_19_31165_2 crossref_primary_10_1007_s11033_021_06405_x crossref_primary_10_1002_mc_22542 crossref_primary_10_1080_16078454_2021_2010330 crossref_primary_10_1186_s40246_019_0252_0 crossref_primary_10_1016_j_smim_2015_11_006 crossref_primary_10_1038_s41419_020_2585_y crossref_primary_10_1186_1757_2215_7_61 crossref_primary_10_1159_000440790 crossref_primary_10_1002_jcb_26077 crossref_primary_10_1007_s13277_015_3744_0 crossref_primary_10_1016_j_bbrc_2024_150888 crossref_primary_10_1016_j_biopha_2016_12_122 crossref_primary_10_1186_s12859_020_03732_x crossref_primary_10_3390_ijms17050735 crossref_primary_10_1007_s13277_015_3596_7 crossref_primary_10_1016_j_semcancer_2017_02_001 |
Cites_doi | 10.1158/0008-5472.CAN-05-1072 10.1074/jbc.M802935200 10.1016/j.yexmp.2010.05.002 10.1038/nrm1644 10.1093/nar/27.5.1251 10.1038/nature03552 10.1371/journal.pone.0002542 10.1038/nature07511 10.1158/0008-5472.CAN-04-1207 10.1158/0008-5472.CAN-07-1936 10.1158/0008-5472.CAN-05-1055 10.1038/sj.onc.1202332 10.1073/pnas.0510565103 10.1074/jbc.M611393200 10.1038/sj.onc.1210856 10.1182/blood.V94.6.1987 10.1242/dev.126.11.2515 10.1186/1756-0500-2-175 10.4049/jimmunol.176.4.2414 10.1016/j.cell.2009.01.002 10.1128/MCB.17.7.3786 10.1016/j.cell.2005.10.043 10.1016/S0092-8674(00)80919-8 10.1038/sj.onc.1210083 10.1016/S0092-8674(00)80576-0 10.1038/ng1077 10.1152/physiolgenomics.00085.2009 10.1242/dev.126.18.4139 10.1016/j.bbrc.2006.09.167 10.1158/0008-5472.CAN-03-3759 10.1053/j.gastro.2007.05.022 10.1186/bcr2843 10.1074/jbc.M110.114736 10.1093/nar/gkn712 10.1091/mbc.E08-02-0159 10.1371/journal.pcbi.0030131 10.1080/10428190902763517 10.1016/j.ccr.2010.08.013 10.1002/path.2222 10.1158/0008-5472.CAN-05-0137 10.1016/S0092-8674(04)00045-5 10.1038/nature03203 |
ContentType | Journal Article |
Copyright | Copyright © 2013 Wiley Periodicals, Inc. |
Copyright_xml | – notice: Copyright © 2013 Wiley Periodicals, Inc. |
DBID | BSCLL AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QL 7QP 7QR 7T7 7TK 7U9 8FD C1K FR3 H94 K9. M7N P64 7X8 |
DOI | 10.1002/jcb.24504 |
DatabaseName | Istex CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Technology Research Database ProQuest Health & Medical Complete (Alumni) Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts Chemoreception Abstracts Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitleList | Virology and AIDS Abstracts CrossRef MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry Biology |
EISSN | 1097-4644 |
EndPage | 1633 |
ExternalDocumentID | 2966587671 23355454 10_1002_jcb_24504 JCB24504 ark_67375_WNG_PHSLDMDH_W |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: The Ministry of Science and Technology of China funderid: 2012ZX09506001‐010; 2012CB722605; 2012AA020305; 2011DFA30620 |
GroupedDBID | --- -~X .3N .GA .GJ .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 31~ 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABPVW ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACIWK ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHMBA AIAGR AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AUFTA AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BLYAC BMNLL BMXJE BNHUX BROTX BRXPI BSCLL BY8 CS3 D-E D-F DCZOG DPXWK DR1 DR2 DRFUL DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA H.T H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IH2 IX1 J0M JPC KQQ LATKE LAW LC2 LC3 LEEKS LH4 LH6 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NDZJH NF~ NNB O66 O9- OIG P2P P2W P2X P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RBB RIWAO RJQFR ROL RWI RX1 RYL SAMSI SUPJJ SV3 UB1 V8K W8V W99 WBKPD WIB WIH WIK WJL WNSPC WOHZO WQJ WRC WSB WXSBR WYISQ XG1 XPP XV2 ZGI ZXP ZZTAW ~IA ~WT AAHQN AAMNL AANHP AAYCA ACRPL ACYXJ ADNMO AFWVQ ALVPJ AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7QL 7QP 7QR 7T7 7TK 7U9 8FD C1K FR3 H94 K9. M7N P64 7X8 |
ID | FETCH-LOGICAL-c3914-6a9908b2d1332c3f59bb76a643963f7af427cc8e56ee5ef177c67bf3b5134b5a3 |
IEDL.DBID | DR2 |
ISSN | 0730-2312 1097-4644 |
IngestDate | Fri Jul 11 01:13:54 EDT 2025 Sun Jul 13 04:47:06 EDT 2025 Mon Jul 21 06:03:26 EDT 2025 Tue Jul 01 03:55:52 EDT 2025 Thu Apr 24 22:57:47 EDT 2025 Wed Jan 22 16:20:28 EST 2025 Wed Oct 30 09:52:17 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor Copyright © 2013 Wiley Periodicals, Inc. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3914-6a9908b2d1332c3f59bb76a643963f7af427cc8e56ee5ef177c67bf3b5134b5a3 |
Notes | istex:EE503DB1CF0A65A5D367381355ACF15205682824 ark:/67375/WNG-PHSLDMDH-W Conflict of interest: nothing to declare. ArticleID:JCB24504 The Ministry of Science and Technology of China - No. 2012ZX09506001-010; No. 2012CB722605; No. 2012AA020305; No. 2011DFA30620 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 23355454 |
PQID | 1349774546 |
PQPubID | 1006368 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_1350894618 proquest_journals_1349774546 pubmed_primary_23355454 crossref_citationtrail_10_1002_jcb_24504 crossref_primary_10_1002_jcb_24504 wiley_primary_10_1002_jcb_24504_JCB24504 istex_primary_ark_67375_WNG_PHSLDMDH_W |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2013-07 July 2013 2013-07-00 2013-Jul 20130701 |
PublicationDateYYYYMMDD | 2013-07-01 |
PublicationDate_xml | – month: 07 year: 2013 text: 2013-07 |
PublicationDecade | 2010 |
PublicationPlace | Hoboken |
PublicationPlace_xml | – name: Hoboken – name: United States |
PublicationTitle | Journal of cellular biochemistry |
PublicationTitleAlternate | J. Cell. Biochem |
PublicationYear | 2013 |
Publisher | Wiley Subscription Services, Inc., A Wiley Company Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc., A Wiley Company – name: Wiley Subscription Services, Inc |
References | Apostolopoulou K, Pateras I, Evangelou K, Tsantoulis P, Liontos M, Kittas C, Tiniakos D, Kotsinas A, Cordon-Cardo C, Gorgoulis V. 2007. Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancer. J Pathol 213:294-302. Zu X, Ma J, Liu H, Liu F, Tan C, Yu L, Wang J, Xie Z, Cao D, Jiang Y. 2011. Pro-oncogene Pokemon promotes breast cancer progression by upregulating survivin expression. Breast Cancer Res 13:R26. Chan JA, Krichevsky AM, Kosik KS. 2005. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65:6029. Chung SW, Chen YH, Yet SF, Layne MD, Perrella MA. 2006. Endotoxin-induced down-regulation of Elk-3 facilitates heme oxygenase-1 induction in macrophages. J Immunol 176:2414. Si M, Zhu S, Wu H, Lu Z, Wu F, Mo Y. 2006. miR-21-mediated tumor growth. Oncogene 26:2799-2803. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S. 2008. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456:980-984. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M. 2006. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103:2257-22261. Sayed D, Rane S, Lypowy J, He M, Chen IY, Vashistha H, Yan L, Malhotra A, Vatner D, Abdellatif M. 2008. MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. Mol Biol Cell 19:3272-3282. Shalgi R, Lieber D, Oren M, Pilpel Y. 2007. Global and local architecture of the mammalian microRNA-transcription factor regulatory network. PLoS Comput Biol 3:e131. Fong CW, Chua MS, McKie AB, Ling SHM, Mason V, Li R, Yusoff P, Lo TL, Leung HY, So SKS. 2006. Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma. Cancer Res 66:2048. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. 2007. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133:647-658. Reich A, Sapir A, Shilo B. 1999. Sprouty is a general inhibitor of receptor tyrosine kinase signaling. Development 126:4139. Chen WY, Zeng X, Carter MG, Morrell CN, Chiu Yen RW, Esteller M, Watkins DN, Herman JG, Mankowski JL, Baylin SB. 2003. Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors. Nat Genet 33:197-202. Zu X, Yu L, Sun Q, Liu F, Wang J, Xie Z, Wang Y, Xu W, Jiang Y. 2009. SP1 enhances Zbtb7A gene expression via direct binding to GC box in HePG2 cells. BMC Res Notes 2:175. Morrison DJ, Pendergrast PS, Stavropoulos P, Colmenares SU, Kobayashi R, Hernandez N. 1999. FBI-1, a factor that binds to the HIV-1 inducer of short transcripts (IST), is a POZ domain protein. Nucleic Acids Res 27:1251. Bartel DP. 2009. MicroRNAs: Target recognition and regulatory functions. Cell 136:215-233. Asangani I, Rasheed S, Nikolova D, Leupold J, Colburn N, Post S, Allgayer H. 2007. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27:2128-2136. Kramer S, Okabe M, Hacohen N, Krasnow MA, Hiromi Y. 1999. Sprouty: A common antagonist of FGF and EGF signaling pathways in Drosophila. Development 126:2515-2525. Kwabi-Addo B, Wang J, Erdem H, Vaid A, Castro P, Ayala G, Ittmann M. 2004. The expression of Sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer. Cancer Res 64:4728. Bartel DP. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116:281-297. Yu X, Lin J, Zack DJ, Mendell JT, Qian J. 2008. Analysis of regulatory network topology reveals functionally distinct classes of microRNAs. Nucleic Acids Res 36:6494-6503. Pessler F, Pendergrast PS, Hernandez N. 1997. Purification and characterization of FBI-1, a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts. Mol Cell Biol 17:3786. Mraz M, Pospisilova S, Malinova K, Slapak I, Mayer J. 2009. MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes. Leuk Lymphoma 50:506-509. Wei CL, Wu Q, Vega VB, Chiu KP, Ng P, Zhang T, Shahab A, Yong HC, Fu YT, Weng Z. 2006. A global map of p53 transcription-factor binding sites in the human genome. Cell 124:207-219. Kukita A, Kukita T, Ouchida M, Maeda H, Yatsuki H, Kohashi O. 1999. Osteoclast-derived zinc finger (OCZF) protein with POZ domain, a possible transcriptional repressor, is involved in osteoclastogenesis. Blood 94:1987-1997. Hacohen N, Kramer S, Sutherland D, Hiromi Y, Krasnow MA. 1998. sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways. Cell 92:253-263. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ. 2005. A microRNA polycistron as a potential human oncogene. Nature 435:828-833. Maeda T, Hobbs RM, Merghoub T, Guernah I, Zelent A, Cordon-Cardo C, Teruya-Feldstein J, Pandolfi PP. 2005a. Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature 433:278-285. Lo TL, Yusoff P, Fong CW, Guo K, McCaw BJ, Phillips WA, Yang H, Wong ESM, Leong HF, Zeng Q. 2004. The ras/mitogen-activated protein kinase pathway inhibitor and likely tumor suppressor proteins, sprouty 1 and sprouty 2 are deregulated in breast cancer. Cancer Res 64:6127-6136. Poliseno L, Pitto L, Simili M, Mariani L, Riccardi L, Ciucci A, Rizzo M, Evangelista M, Mercatanti A, Pandolfi PP. 2008. The proto-oncogene LRF is under post-transcriptional control of MiR-20a: Implications for senescence. PLoS ONE 3:e2542. Kim VN. 2005. MicroRNA biogenesis: Coordinated cropping and dicing. Nat Rev Mol Cell Biol 6:376-385. Schubot FD, Tropea JE, Waugh DS. 2006. Structure of the POZ domain of human LRF, a master regulator of oncogenesis. Biochem Biophys Res Commun 351:1-6. Jeon BN, Yoo JY, Choi WI, Lee CE, Yoon HG, Hur MW. 2008. Proto-oncogene FBI-1 (Pokemon/ZBTB7A) represses transcription of the tumor suppressor Rb gene via binding competition with Sp1 and recruitment of co-repressors. J Biol Chem 283:33199-33210. Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H. 2007. MicroRNA signatures in human ovarian cancer. Cancer Res 67:8699. Maeda T, Hobbs RM, Pandolfi PP. 2005b. The transcription factor Pokemon: A new key player in cancer pathogenesis. Cancer Res 65:8575. Verduci L, Simili M, Rizzo M, Mercatanti A, Evangelista M, Mariani L, Rainaldi G, Pitto L. 2010. MicroRNA (miRNA)-mediated interaction between leukemia/lymphoma-related factor (LRF) and alternative splicing factor/splicing factor 2 (ASF/SF2) affects mouse embryonic fibroblast senescence and apoptosis. J Biol Chem 285:39551. Hatley ME, Patrick DM, Garcia MR, Richardson JA, Bassel-Duby R, Van Rooij E, Olson EN. 2010. Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell 18:282-293. Aggarwal A, Hunter WJ III, Aggarwal H, Silva ED, Davey MS, Murphy RF, Agrawal DK. 2010. Expression of leukemia/lymphoma-related factor (LRF/POKEMON) in human breast carcinoma and other cancers. Exp Mol Pathol 89:140-148. Davies J, Hawe N, Kabarowski J, Huang Q, Zhu J, Brand N, Leprince D, Dhordain P, Cook M, Morriss-Kay G. 1999. Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene. Oncogene 18:365. Pitto L, Rizzo M, Simili M, Colligiani D, Evangelista M, Mercatanti A, Mariani L, Cremisi F, Rainaldi G. 2009. miR-290 acts as a physiological effector of senescence in mouse embryo fibroblasts. Physiol Genomics 39:210-218. Zhu S, Si ML, Wu H, Mo YY. 2007. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282:14328. Casci T, Vinós J, Freeman M. 1999. Sprouty, an intracellular inhibitor of Ras signaling. Cell 96:655-665. 2004; 64 2007; 282 2010; 18 1999; 27 2008; 19 2005; 435 2008; 36 2006; 176 2005; 65 2006; 351 2010; 285 2011; 13 2005a; 433 2008; 3 1999; 126 2009; 136 2008; 283 2003; 33 2010; 89 2007; 213 2004; 116 2009; 50 1999; 18 2006; 66 2007; 133 2006; 26 2005b; 65 1997; 17 2005; 6 1998; 92 1999; 96 2008; 456 1999; 94 2007; 3 2009; 2 2007; 67 2006; 103 2007; 27 2009; 39 2006; 124 e_1_2_5_27_1 e_1_2_5_28_1 e_1_2_5_25_1 e_1_2_5_26_1 e_1_2_5_23_1 e_1_2_5_24_1 e_1_2_5_21_1 e_1_2_5_22_1 e_1_2_5_43_1 e_1_2_5_29_1 e_1_2_5_42_1 e_1_2_5_41_1 e_1_2_5_40_1 e_1_2_5_15_1 e_1_2_5_38_1 e_1_2_5_14_1 e_1_2_5_39_1 e_1_2_5_17_1 e_1_2_5_36_1 e_1_2_5_9_1 e_1_2_5_16_1 e_1_2_5_37_1 e_1_2_5_8_1 e_1_2_5_11_1 e_1_2_5_34_1 e_1_2_5_7_1 e_1_2_5_10_1 e_1_2_5_35_1 e_1_2_5_6_1 e_1_2_5_13_1 e_1_2_5_32_1 e_1_2_5_5_1 e_1_2_5_12_1 Kukita A (e_1_2_5_20_1) 1999; 94 e_1_2_5_33_1 e_1_2_5_4_1 e_1_2_5_3_1 e_1_2_5_2_1 e_1_2_5_19_1 e_1_2_5_18_1 e_1_2_5_30_1 e_1_2_5_31_1 |
References_xml | – reference: Bartel DP. 2009. MicroRNAs: Target recognition and regulatory functions. Cell 136:215-233. – reference: Jeon BN, Yoo JY, Choi WI, Lee CE, Yoon HG, Hur MW. 2008. Proto-oncogene FBI-1 (Pokemon/ZBTB7A) represses transcription of the tumor suppressor Rb gene via binding competition with Sp1 and recruitment of co-repressors. J Biol Chem 283:33199-33210. – reference: Morrison DJ, Pendergrast PS, Stavropoulos P, Colmenares SU, Kobayashi R, Hernandez N. 1999. FBI-1, a factor that binds to the HIV-1 inducer of short transcripts (IST), is a POZ domain protein. Nucleic Acids Res 27:1251. – reference: Reich A, Sapir A, Shilo B. 1999. Sprouty is a general inhibitor of receptor tyrosine kinase signaling. Development 126:4139. – reference: Davies J, Hawe N, Kabarowski J, Huang Q, Zhu J, Brand N, Leprince D, Dhordain P, Cook M, Morriss-Kay G. 1999. Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene. Oncogene 18:365. – reference: Schubot FD, Tropea JE, Waugh DS. 2006. Structure of the POZ domain of human LRF, a master regulator of oncogenesis. Biochem Biophys Res Commun 351:1-6. – reference: Kim VN. 2005. MicroRNA biogenesis: Coordinated cropping and dicing. Nat Rev Mol Cell Biol 6:376-385. – reference: Bartel DP. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116:281-297. – reference: Apostolopoulou K, Pateras I, Evangelou K, Tsantoulis P, Liontos M, Kittas C, Tiniakos D, Kotsinas A, Cordon-Cardo C, Gorgoulis V. 2007. Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancer. J Pathol 213:294-302. – reference: Chan JA, Krichevsky AM, Kosik KS. 2005. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65:6029. – reference: Chung SW, Chen YH, Yet SF, Layne MD, Perrella MA. 2006. Endotoxin-induced down-regulation of Elk-3 facilitates heme oxygenase-1 induction in macrophages. J Immunol 176:2414. – reference: Maeda T, Hobbs RM, Pandolfi PP. 2005b. The transcription factor Pokemon: A new key player in cancer pathogenesis. Cancer Res 65:8575. – reference: Si M, Zhu S, Wu H, Lu Z, Wu F, Mo Y. 2006. miR-21-mediated tumor growth. Oncogene 26:2799-2803. – reference: Kwabi-Addo B, Wang J, Erdem H, Vaid A, Castro P, Ayala G, Ittmann M. 2004. The expression of Sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer. Cancer Res 64:4728. – reference: Zu X, Yu L, Sun Q, Liu F, Wang J, Xie Z, Wang Y, Xu W, Jiang Y. 2009. SP1 enhances Zbtb7A gene expression via direct binding to GC box in HePG2 cells. BMC Res Notes 2:175. – reference: Aggarwal A, Hunter WJ III, Aggarwal H, Silva ED, Davey MS, Murphy RF, Agrawal DK. 2010. Expression of leukemia/lymphoma-related factor (LRF/POKEMON) in human breast carcinoma and other cancers. Exp Mol Pathol 89:140-148. – reference: Verduci L, Simili M, Rizzo M, Mercatanti A, Evangelista M, Mariani L, Rainaldi G, Pitto L. 2010. MicroRNA (miRNA)-mediated interaction between leukemia/lymphoma-related factor (LRF) and alternative splicing factor/splicing factor 2 (ASF/SF2) affects mouse embryonic fibroblast senescence and apoptosis. J Biol Chem 285:39551. – reference: Zu X, Ma J, Liu H, Liu F, Tan C, Yu L, Wang J, Xie Z, Cao D, Jiang Y. 2011. Pro-oncogene Pokemon promotes breast cancer progression by upregulating survivin expression. Breast Cancer Res 13:R26. – reference: Hacohen N, Kramer S, Sutherland D, Hiromi Y, Krasnow MA. 1998. sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways. Cell 92:253-263. – reference: Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. 2007. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133:647-658. – reference: Poliseno L, Pitto L, Simili M, Mariani L, Riccardi L, Ciucci A, Rizzo M, Evangelista M, Mercatanti A, Pandolfi PP. 2008. The proto-oncogene LRF is under post-transcriptional control of MiR-20a: Implications for senescence. PLoS ONE 3:e2542. – reference: Sayed D, Rane S, Lypowy J, He M, Chen IY, Vashistha H, Yan L, Malhotra A, Vatner D, Abdellatif M. 2008. MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. Mol Biol Cell 19:3272-3282. – reference: Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S. 2008. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456:980-984. – reference: Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M. 2006. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103:2257-22261. – reference: Zhu S, Si ML, Wu H, Mo YY. 2007. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282:14328. – reference: Pitto L, Rizzo M, Simili M, Colligiani D, Evangelista M, Mercatanti A, Mariani L, Cremisi F, Rainaldi G. 2009. miR-290 acts as a physiological effector of senescence in mouse embryo fibroblasts. Physiol Genomics 39:210-218. – reference: Hatley ME, Patrick DM, Garcia MR, Richardson JA, Bassel-Duby R, Van Rooij E, Olson EN. 2010. Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell 18:282-293. – reference: Kukita A, Kukita T, Ouchida M, Maeda H, Yatsuki H, Kohashi O. 1999. Osteoclast-derived zinc finger (OCZF) protein with POZ domain, a possible transcriptional repressor, is involved in osteoclastogenesis. Blood 94:1987-1997. – reference: Fong CW, Chua MS, McKie AB, Ling SHM, Mason V, Li R, Yusoff P, Lo TL, Leung HY, So SKS. 2006. Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma. Cancer Res 66:2048. – reference: Mraz M, Pospisilova S, Malinova K, Slapak I, Mayer J. 2009. MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes. Leuk Lymphoma 50:506-509. – reference: Asangani I, Rasheed S, Nikolova D, Leupold J, Colburn N, Post S, Allgayer H. 2007. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27:2128-2136. – reference: Lo TL, Yusoff P, Fong CW, Guo K, McCaw BJ, Phillips WA, Yang H, Wong ESM, Leong HF, Zeng Q. 2004. The ras/mitogen-activated protein kinase pathway inhibitor and likely tumor suppressor proteins, sprouty 1 and sprouty 2 are deregulated in breast cancer. Cancer Res 64:6127-6136. – reference: Kramer S, Okabe M, Hacohen N, Krasnow MA, Hiromi Y. 1999. Sprouty: A common antagonist of FGF and EGF signaling pathways in Drosophila. Development 126:2515-2525. – reference: He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ. 2005. A microRNA polycistron as a potential human oncogene. Nature 435:828-833. – reference: Yu X, Lin J, Zack DJ, Mendell JT, Qian J. 2008. Analysis of regulatory network topology reveals functionally distinct classes of microRNAs. Nucleic Acids Res 36:6494-6503. – reference: Wei CL, Wu Q, Vega VB, Chiu KP, Ng P, Zhang T, Shahab A, Yong HC, Fu YT, Weng Z. 2006. A global map of p53 transcription-factor binding sites in the human genome. Cell 124:207-219. – reference: Chen WY, Zeng X, Carter MG, Morrell CN, Chiu Yen RW, Esteller M, Watkins DN, Herman JG, Mankowski JL, Baylin SB. 2003. Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors. Nat Genet 33:197-202. – reference: Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H. 2007. MicroRNA signatures in human ovarian cancer. Cancer Res 67:8699. – reference: Casci T, Vinós J, Freeman M. 1999. Sprouty, an intracellular inhibitor of Ras signaling. Cell 96:655-665. – reference: Pessler F, Pendergrast PS, Hernandez N. 1997. Purification and characterization of FBI-1, a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts. Mol Cell Biol 17:3786. – reference: Shalgi R, Lieber D, Oren M, Pilpel Y. 2007. Global and local architecture of the mammalian microRNA-transcription factor regulatory network. PLoS Comput Biol 3:e131. – reference: Maeda T, Hobbs RM, Merghoub T, Guernah I, Zelent A, Cordon-Cardo C, Teruya-Feldstein J, Pandolfi PP. 2005a. Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature 433:278-285. – volume: 103 start-page: 2257 year: 2006 end-page: 22261 article-title: A microRNA expression signature of human solid tumors defines cancer gene targets publication-title: Proc Natl Acad Sci USA – volume: 116 start-page: 281 year: 2004 end-page: 297 article-title: MicroRNAs: Genomics, biogenesis, mechanism, and function publication-title: Cell – volume: 6 start-page: 376 year: 2005 end-page: 385 article-title: MicroRNA biogenesis: Coordinated cropping and dicing publication-title: Nat Rev Mol Cell Biol – volume: 64 start-page: 6127 year: 2004 end-page: 6136 article-title: The ras/mitogen‐activated protein kinase pathway inhibitor and likely tumor suppressor proteins, sprouty 1 and sprouty 2 are deregulated in breast cancer publication-title: Cancer Res – volume: 433 start-page: 278 year: 2005a end-page: 285 article-title: Role of the proto‐oncogene Pokemon in cellular transformation and ARF repression publication-title: Nature – volume: 2 start-page: 175 year: 2009 article-title: SP1 enhances Zbtb7A gene expression via direct binding to GC box in HePG2 cells publication-title: BMC Res Notes – volume: 39 start-page: 210 year: 2009 end-page: 218 article-title: miR‐290 acts as a physiological effector of senescence in mouse embryo fibroblasts publication-title: Physiol Genomics – volume: 3 start-page: e2542 year: 2008 article-title: The proto‐oncogene LRF is under post‐transcriptional control of MiR‐20a: Implications for senescence publication-title: PLoS ONE – volume: 64 start-page: 4728 year: 2004 article-title: The expression of Sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer publication-title: Cancer Res – volume: 65 start-page: 8575 year: 2005b article-title: The transcription factor Pokemon: A new key player in cancer pathogenesis publication-title: Cancer Res – volume: 283 start-page: 33199 year: 2008 end-page: 33210 article-title: Proto‐oncogene FBI‐1 (Pokemon/ZBTB7A) represses transcription of the tumor suppressor Rb gene via binding competition with Sp1 and recruitment of co‐repressors publication-title: J Biol Chem – volume: 36 start-page: 6494 year: 2008 end-page: 6503 article-title: Analysis of regulatory network topology reveals functionally distinct classes of microRNAs publication-title: Nucleic Acids Res – volume: 17 start-page: 3786 year: 1997 article-title: Purification and characterization of FBI‐1, a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts publication-title: Mol Cell Biol – volume: 33 start-page: 197 year: 2003 end-page: 202 article-title: Heterozygous disruption of Hic1 predisposes mice to a gender‐dependent spectrum of malignant tumors publication-title: Nat Genet – volume: 18 start-page: 365 year: 1999 article-title: Novel BTB/POZ domain zinc‐finger protein, LRF, is a potential target of the LAZ‐3/BCL‐6 oncogene publication-title: Oncogene – volume: 89 start-page: 140 year: 2010 end-page: 148 article-title: Expression of leukemia/lymphoma‐related factor (LRF/POKEMON) in human breast carcinoma and other cancers publication-title: Exp Mol Pathol – volume: 19 start-page: 3272 year: 2008 end-page: 3282 article-title: MicroRNA‐21 targets Sprouty2 and promotes cellular outgrowths publication-title: Mol Biol Cell – volume: 126 start-page: 4139 year: 1999 article-title: Sprouty is a general inhibitor of receptor tyrosine kinase signaling publication-title: Development – volume: 26 start-page: 2799 year: 2006 end-page: 2803 article-title: miR‐21‐mediated tumor growth publication-title: Oncogene – volume: 435 start-page: 828 year: 2005 end-page: 833 article-title: A microRNA polycistron as a potential human oncogene publication-title: Nature – volume: 213 start-page: 294 year: 2007 end-page: 302 article-title: Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non‐small cell lung cancer publication-title: J Pathol – volume: 124 start-page: 207 year: 2006 end-page: 219 article-title: A global map of p53 transcription‐factor binding sites in the human genome publication-title: Cell – volume: 67 start-page: 8699 year: 2007 article-title: MicroRNA signatures in human ovarian cancer publication-title: Cancer Res – volume: 456 start-page: 980 year: 2008 end-page: 984 article-title: MicroRNA‐21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts publication-title: Nature – volume: 27 start-page: 1251 year: 1999 article-title: FBI‐1, a factor that binds to the HIV‐1 inducer of short transcripts (IST), is a POZ domain protein publication-title: Nucleic Acids Res – volume: 282 start-page: 14328 year: 2007 article-title: MicroRNA‐21 targets the tumor suppressor gene tropomyosin 1 (TPM1) publication-title: J Biol Chem – volume: 176 start-page: 2414 year: 2006 article-title: Endotoxin‐induced down‐regulation of Elk‐3 facilitates heme oxygenase‐1 induction in macrophages publication-title: J Immunol – volume: 18 start-page: 282 year: 2010 end-page: 293 article-title: Modulation of K‐Ras‐dependent lung tumorigenesis by MicroRNA‐21 publication-title: Cancer Cell – volume: 94 start-page: 1987 year: 1999 end-page: 1997 article-title: Osteoclast‐derived zinc finger (OCZF) protein with POZ domain, a possible transcriptional repressor, is involved in osteoclastogenesis publication-title: Blood – volume: 285 start-page: 39551 year: 2010 article-title: MicroRNA (miRNA)‐mediated interaction between leukemia/lymphoma‐related factor (LRF) and alternative splicing factor/splicing factor 2 (ASF/SF2) affects mouse embryonic fibroblast senescence and apoptosis publication-title: J Biol Chem – volume: 96 start-page: 655 year: 1999 end-page: 665 article-title: Sprouty, an intracellular inhibitor of Ras signaling publication-title: Cell – volume: 50 start-page: 506 year: 2009 end-page: 509 article-title: MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes publication-title: Leuk Lymphoma – volume: 126 start-page: 2515 year: 1999 end-page: 2525 article-title: Sprouty: A common antagonist of FGF and EGF signaling pathways in Drosophila publication-title: Development – volume: 92 start-page: 253 year: 1998 end-page: 263 article-title: sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways publication-title: Cell – volume: 27 start-page: 2128 year: 2007 end-page: 2136 article-title: MicroRNA‐21 (miR‐21) post‐transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer publication-title: Oncogene – volume: 3 start-page: e131 year: 2007 article-title: Global and local architecture of the mammalian microRNA‐transcription factor regulatory network publication-title: PLoS Comput Biol – volume: 133 start-page: 647 year: 2007 end-page: 658 article-title: MicroRNA‐21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer publication-title: Gastroenterology – volume: 66 start-page: 2048 year: 2006 article-title: Sprouty 2, an inhibitor of mitogen‐activated protein kinase signaling, is down‐regulated in hepatocellular carcinoma publication-title: Cancer Res – volume: 65 start-page: 6029 year: 2005 article-title: MicroRNA‐21 is an antiapoptotic factor in human glioblastoma cells publication-title: Cancer Res – volume: 351 start-page: 1 year: 2006 end-page: 6 article-title: Structure of the POZ domain of human LRF, a master regulator of oncogenesis publication-title: Biochem Biophys Res Commun – volume: 136 start-page: 215 year: 2009 end-page: 233 article-title: MicroRNAs: Target recognition and regulatory functions publication-title: Cell – volume: 13 start-page: R26 year: 2011 article-title: Pro‐oncogene Pokemon promotes breast cancer progression by upregulating survivin expression publication-title: Breast Cancer Res – ident: e_1_2_5_12_1 doi: 10.1158/0008-5472.CAN-05-1072 – ident: e_1_2_5_17_1 doi: 10.1074/jbc.M802935200 – ident: e_1_2_5_2_1 doi: 10.1016/j.yexmp.2010.05.002 – ident: e_1_2_5_18_1 doi: 10.1038/nrm1644 – ident: e_1_2_5_26_1 doi: 10.1093/nar/27.5.1251 – ident: e_1_2_5_15_1 doi: 10.1038/nature03552 – ident: e_1_2_5_30_1 doi: 10.1371/journal.pone.0002542 – ident: e_1_2_5_36_1 doi: 10.1038/nature07511 – ident: e_1_2_5_22_1 doi: 10.1158/0008-5472.CAN-04-1207 – ident: e_1_2_5_16_1 doi: 10.1158/0008-5472.CAN-07-1936 – ident: e_1_2_5_24_1 doi: 10.1158/0008-5472.CAN-05-1055 – ident: e_1_2_5_11_1 doi: 10.1038/sj.onc.1202332 – ident: e_1_2_5_38_1 doi: 10.1073/pnas.0510565103 – ident: e_1_2_5_41_1 doi: 10.1074/jbc.M611393200 – ident: e_1_2_5_4_1 doi: 10.1038/sj.onc.1210856 – volume: 94 start-page: 1987 year: 1999 ident: e_1_2_5_20_1 article-title: Osteoclast‐derived zinc finger (OCZF) protein with POZ domain, a possible transcriptional repressor, is involved in osteoclastogenesis publication-title: Blood doi: 10.1182/blood.V94.6.1987 – ident: e_1_2_5_19_1 doi: 10.1242/dev.126.11.2515 – ident: e_1_2_5_42_1 doi: 10.1186/1756-0500-2-175 – ident: e_1_2_5_10_1 doi: 10.4049/jimmunol.176.4.2414 – ident: e_1_2_5_6_1 doi: 10.1016/j.cell.2009.01.002 – ident: e_1_2_5_28_1 doi: 10.1128/MCB.17.7.3786 – ident: e_1_2_5_39_1 doi: 10.1016/j.cell.2005.10.043 – ident: e_1_2_5_13_1 doi: 10.1016/S0092-8674(00)80919-8 – ident: e_1_2_5_35_1 doi: 10.1038/sj.onc.1210083 – ident: e_1_2_5_7_1 doi: 10.1016/S0092-8674(00)80576-0 – ident: e_1_2_5_9_1 doi: 10.1038/ng1077 – ident: e_1_2_5_29_1 doi: 10.1152/physiolgenomics.00085.2009 – ident: e_1_2_5_31_1 doi: 10.1242/dev.126.18.4139 – ident: e_1_2_5_33_1 doi: 10.1016/j.bbrc.2006.09.167 – ident: e_1_2_5_21_1 doi: 10.1158/0008-5472.CAN-03-3759 – ident: e_1_2_5_25_1 doi: 10.1053/j.gastro.2007.05.022 – ident: e_1_2_5_43_1 doi: 10.1186/bcr2843 – ident: e_1_2_5_37_1 doi: 10.1074/jbc.M110.114736 – ident: e_1_2_5_40_1 doi: 10.1093/nar/gkn712 – ident: e_1_2_5_32_1 doi: 10.1091/mbc.E08-02-0159 – ident: e_1_2_5_34_1 doi: 10.1371/journal.pcbi.0030131 – ident: e_1_2_5_27_1 doi: 10.1080/10428190902763517 – ident: e_1_2_5_14_1 doi: 10.1016/j.ccr.2010.08.013 – ident: e_1_2_5_3_1 doi: 10.1002/path.2222 – ident: e_1_2_5_8_1 doi: 10.1158/0008-5472.CAN-05-0137 – ident: e_1_2_5_5_1 doi: 10.1016/S0092-8674(04)00045-5 – ident: e_1_2_5_23_1 doi: 10.1038/nature03203 |
SSID | ssj0009932 |
Score | 2.2388926 |
Snippet | Transcriptional repressor Pokemon is a critical factor in embryogenesis, development, cell proliferation, differentiation, and oncogenesis, thus behaving as an... |
SourceID | proquest pubmed crossref wiley istex |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1625 |
SubjectTerms | Adaptor Proteins, Signal Transducing Blotting, Western Carcinoma, Hepatocellular - genetics Carcinoma, Hepatocellular - metabolism Cell Proliferation Chromatin Immunoprecipitation DNA-Binding Proteins - genetics DNA-Binding Proteins - metabolism Embryonic growth stage Gene Expression Regulation, Neoplastic - genetics Gene Expression Regulation, Neoplastic - physiology Humans LIVER CANCER Liver Neoplasms - genetics Liver Neoplasms - metabolism Membrane Proteins - genetics Membrane Proteins - metabolism microRNA 21 MicroRNAs - genetics MicroRNAs - metabolism Mutagenesis, Site-Directed Phosphoproteins - genetics Phosphoproteins - metabolism POKEMON Promoter Regions, Genetic - genetics Real-Time Polymerase Chain Reaction siRNA Sprouty1 Transcription Factors - genetics Transcription Factors - metabolism |
Title | microRNA 21-mediated suppression of sprouty1 by Pokemon affects liver cancer cell growth and proliferation |
URI | https://api.istex.fr/ark:/67375/WNG-PHSLDMDH-W/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjcb.24504 https://www.ncbi.nlm.nih.gov/pubmed/23355454 https://www.proquest.com/docview/1349774546 https://www.proquest.com/docview/1350894618 |
Volume | 114 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9RAFB5KRfTFS71Fq4wi0pdsN3NN8KlurUuxS6mW9kEYZiYzlm5Mlt0Nuj75E_yN_hJnJpdSqSA-JZATMjnznZwvyZnvAPBymFNrTZrHQ6XTmNDExKnFSaxdNleZRpiH3oAHEzY-Jvun9HQNvO7WwjT6EP0HNx8Z4XntA1yqxfaFaOi5VgNEaNAC9bVanhAdXUhHubwb_iA4BMeOw6BOVWiItvszL-Wia96t364impd5a0g8e7fBp27ITb3JdFAv1UB__0PN8T_v6Q641RJSuNMg6C5YM-UGuN60qFxtgBujriPcPVB88dV7R5MdiJJfP36GRSeOsMJFPWvLaUtYWbhwQ62XqwSqFTyspsYBHcqmbAQWvgwEag81tzFFAT_Pq6_LMyjLHM58ByFrGkzeB8d7bz-OxnHbrSHWOEtIzKRLbKlCuXvrRRpbminFmfSMh2HLpSWIa50ayoyhxiaca8aVxYommCgq8QOwXlaleQRgRnCe58QS967qCCVLmbKI82FYRqsyGYGtbt6EbqXMfUeNQjQizEg4R4rgyAi86E1njX7HVUavwuT3FnI-9QVvnIqTyTtxOP7wfvdgdyxOIrDZoUO0sb4QXuDRkWhKWASe94fd1HgvytJUtbdxRDgjLEkj8LBBVX8xhD3no24UWwEbfx-n2B-9CTuP_930CbiJQgcPX2G8CdaX89o8dTxqqZ6FgPkNBeAXUA |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VVqhceJTXQgGDAPWSbeLYeRw4lF1K2u6uqtKqvZnYsUHskqz2obKc-An8EP4Kf4Jfgu08qqIicemBUyJllDieGc83yfgbgOduRpWSUea4XEQOoZ50IuV7jtDRnMcC-6HtDdgfBMkR2T2hJ0vwo94LU_JDNB_cjGfY9do4uPkgvXnGGvpJ8DYm1CVVSeWeXJzqhG36aqertfsC4-03h53EqXoKOMKPPeIEqV5-I44znZth4Ssacx4GqYnLga_CVBEcChFJGkhJpfLCUAQhVz6nnk84TX193yuwYjqIG6b-7sEZWZWO9PafhfYZR6MmXPMYuXizGeq56LdiFPnlImh7HinbULd9A37Wk1RWuAzb8xlvi69_8Ef-L7N4E65XmBttlU5yC5ZkvgZXyy6cizVY7dRN727D6LMpUDwYbCHs_fr23e6r0ZgcTefjqmI4R4VCUz0389nCQ3yB9ouh1L6M0rIyBo1MpQsSxpv0QY5G6MOkOJ19RGmeobFpkqRk6XZ34OhSXvsuLOdFLu8DiomfZRlRRKfjGjMHUcAVDkPX7hTmcdqCjdpQmKjY2k3TkBEreaYx04pjVnEteNaIjkuKkouEXlprayTSydDU9IWUHQ_esv3kXa_b7ybsuAXrtTmyajmbMsNhqfMESoIWPG0ua9WYWUxzWcyNjMb6MQm8qAX3SjNuHoZ9A2upHsWGNca_j5Ptdl7bkwf_LvoEVpPDfo_1dgZ7D-Eatg1LTEH1OizPJnP5SMPGGX9svRXB-8s27N_T2HTG |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VVjwuPMproYBBgHrJNnFsJzlwKLss29dq1VK1NxM7Nohdsqt9qCwnfgL_g7_Cr-CXYDuPqqhIXHrglEgZJY5nxvNNMv4G4LmfUa1VnHm-kLFHaKC8WIeBJ000F4nEYeR6A-71WPeQbB_T4yX4Ue2FKfgh6g9u1jPcem0dfJzpjVPS0E9SNDGhPikrKnfU4sTka9NXW22j3BcYd968a3W9sqWAJ8MkIB5LzeobC5yZ1AzLUNNEiIilNiyzUEepJjiSMlaUKUWVDqJIskjoUNAgJIKmobnvJVghzE9sn4j2_ilXlQn07peFcRnPgCZc0Rj5eKMe6pngt2L1-OU8ZHsWKLtI17kBP6s5KgpcBs35TDTl1z_oI_-TSbwJ10vEjTYLF7kFSypfhctFD87FKlxtVS3vbsPwsy1P3O9tIhz8-vbd7aoxiBxN5-OyXjhHI42mZmrms0WAxAL1RwNlPBmlRV0MGto6FyStL5mDGg7Rh8noZPYRpXmGxrZFklaF092Bwwt57buwnI9ydR9QQsIsy4gmJhk3iJnFTGgcRb7bJyyStAHrlZ1wWXK125YhQ16wTGNuFMed4hrwrBYdFwQl5wm9dMZWS6STga3oiyg_6r3l_e7Bbnuv3eVHDVirrJGXi9mUWwZLkyVQwhrwtL5sVGNnMc3VaG5lDNJPCAviBtwrrLh-GA4tqKVmFOvOFv8-Tr7deu1OHvy76BO40m93-O5Wb-chXMOuW4mtpl6D5dlkrh4ZzDgTj52vInh_0Xb9G-lxc3U |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=microRNA+21-mediated+suppression+of+Sprouty1+by+Pokemon+affects+liver+cancer+cell+growth+and+proliferation&rft.jtitle=Journal+of+cellular+biochemistry&rft.au=Jin%2C+Xiu-Li&rft.au=Sun%2C+Qin-Sheng&rft.au=Liu%2C+Feng&rft.au=Yang%2C+Hong-Wei&rft.date=2013-07-01&rft.eissn=1097-4644&rft.volume=114&rft.issue=7&rft.spage=1625&rft_id=info:doi/10.1002%2Fjcb.24504&rft_id=info%3Apmid%2F23355454&rft.externalDocID=23355454 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0730-2312&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0730-2312&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0730-2312&client=summon |